{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-095513","form_type":"8-K","ticker":"DMII","cik":"0002040475","company_name":"Drugs Made In America Acquisition II Corp.","filed_at":"2025-10-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.435966+00:00","generated_at":"2026-05-17T04:59:00.416309+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Drugs Made In America Acquisition II closes $500M IPO and $12M private placement","bullets":["IPO of 50M units at $10 each grossed $500M; units trade on Nasdaq (DMIIU).","Private placement of 1.2M units to sponsor and Cantor Fitzgerald raised $12M.","$500M deposited into trust account; company has 24 months to complete initial business combination.","Balance sheet: $1.58M cash, $17.5M deferred underwriting liability, $17.2M accumulated deficit.","Auditor includes going concern qualification due to mandatory liquidation if no business combination within 24 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-095513","json":"https://secwatch.observer/filing/0001213900-25-095513.json","markdown":"https://secwatch.observer/filing/0001213900-25-095513.md","text":"https://secwatch.observer/filing/0001213900-25-095513.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025095513/0001213900-25-095513-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025095513/ea0259662-8k_drugs2.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:59:00.416309+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}